AJR Am J Roentgenol
-
Correction for: "ADC Values for Detecting Bowel Inflammation and Biologic Therapy
Response in Patients With Crohn Disease: A Post Hoc Prospective Trial Analysis".
AJR Am J Roentgenol. 2024;222:e2430951.
Aliment Pharmacol Ther
- GARCIA MJ, Riestra S, Amiot A, Julsgaard M, et al
Effectiveness and safety of a third-line rescue treatment for acute severe
ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
Aliment Pharmacol Ther. 2024 Mar 6. doi: 10.1111/apt.17938.
- LU C, Rosentreter R, Delisle M, White M, et al
Systematic review: Defining, diagnosing and monitoring small bowel strictures in
Crohn's disease on intestinal ultrasound.
Aliment Pharmacol Ther. 2024 Mar 4. doi: 10.1111/apt.17918.
- BOKEMEYER B, Plachta-Danielzik S, Steiner IM, Pohlschneider D, et al
Inflammatory bowel disease (IBD) patients with impaired quality of life on
biologic therapy benefit from the support of an IBD nurse specialist: Results of
a randomised controlled trial in Germany (IBD(BIO-ASSIST) study).
Aliment Pharmacol Ther. 2024 Mar 1. doi: 10.1111/apt.17926.
Am J Gastroenterol
- EBACH DR, Jester TW, Galanko JA, Firestine AM, et al
High Body Mass Index and Response to Anti-TNF Therapy in Pediatric Crohn Disease.
Am J Gastroenterol. 2024 Mar 6. doi: 10.14309/ajg.0000000000002741.
BMC Gastroenterol
- HU N, Liu J, Gao X, Tang H, et al
The association between hemoglobin level and sarcopenia in Chinese patients with
Crohn's disease.
BMC Gastroenterol. 2024;24:95.
Clin Gastroenterol Hepatol
- NARULA N, Wong ECL, Dulai PS, Patel J, et al
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds
Associated with Low Risk of Disease Progression.
Clin Gastroenterol Hepatol. 2024 Feb 28:S1542-3565(24)00212.
- WIJNANDS AM, Penning de Vries BBL, Lutgens MWMD, Bakhshi Z, et al
Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel
disease.
Clin Gastroenterol Hepatol. 2024 Feb 29:S1542-3565(24)00214.
- AXELRAD JE, Rubin DT
The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel
Disease.
Clin Gastroenterol Hepatol. 2024 Feb 29:S1542-3565(24)00108.
Dig Dis Sci
- OLIVEIRA R, Martins V, de Sousa HT, Roseira J, et al
Food-Related Quality of Life and Its Predictors in Inflammatory Bowel Disease.
Dig Dis Sci. 2024 Mar 8. doi: 10.1007/s10620-024-08333.
Dis Colon Rectum
- SPINELLI A
Expert Commentary on Ileoanal Pouch Construction for Inflammatory Bowel Disease.
Dis Colon Rectum. 2024 Mar 5. doi: 10.1097/DCR.0000000000003330.
- OBI M, Holubar SD
Ileoanal Pouch Construction for Inflammatory Bowel Disease.
Dis Colon Rectum. 2024 Mar 5. doi: 10.1097/DCR.0000000000003329.
- PARASCANDOLA SA, McChesney SL, Khan A
Construction of an Endoluminal Vacuum Using Readily Available Supplies for the
Management of Leak After IPAA.
Dis Colon Rectum. 2024;67:e248-e249.
- RAM E, Zager Y, Carter D, Saukhat O, et al
A Prospective, Single-Arm Study to Evaluate the Safety and Efficacy of an
Autologous Blood Clot Product in the Treatment of Anal Fistula.
Dis Colon Rectum. 2024;67:541-548.
Gastroenterol Hepatol
- NAVARRO-GERRARD C, Calafat M, Benitez JM, Suarez-Ferrer C, et al
Are biologic agents effective and safe in patients with IBD and solid organ
transplantation?
Gastroenterol Hepatol. 2024;47:289-292.
- LASA J, Smolarczuk A, Navar S, Ponce C, et al
Endoscopic scoring system utilization for inflammatory bowel disease activity
assessment: A multicenter real-world study from Argentina.
Gastroenterol Hepatol. 2024;47:253-261.
Gastroenterology
- MITEV S, Marinova C, Spassova Z
A colorful conundrum: dark urine in a patient with inflammatory bowel disease.
Gastroenterology. 2024 Mar 5:S0016-5085(24)00249.
Inflamm Bowel Dis
- FAMUTIMI D, Alayo QA, Deepak P
Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical
Prediction Models in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Mar 8:izae049. doi: 10.1093.
- GEESALA R, Zhang K, Lin YM, Johnson JC, et al
Exclusive Enteral Nutrition Alleviates Th17-Mediated Inflammation via Eliminating
Mechanical Stress-Induced Th17-Polarizing Cytokines in Crohn's-like Colitis.
Inflamm Bowel Dis. 2024;30:429-440.
- TSE CS, Hunt MG, Brown LA, Lewis JD, et al
Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and
Interventions.
Inflamm Bowel Dis. 2024;30:501-507.
- HESAMPOUR F, Bernstein CN, Ghia JE
Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations,
and Potential Therapeutic Approaches.
Inflamm Bowel Dis. 2024;30:482-495.
- D'AMICO F, Peyrin-Biroulet L, Danese S
Disease Clearance is not Synonymous with Cure.
Inflamm Bowel Dis. 2024;30:509.
- HOXHA T, Youssef M, Huang V, Tandon P, et al
Inflammatory Bowel Disease and Breastfeeding: A Narrative Review.
Inflamm Bowel Dis. 2024 Mar 4:izae033. doi: 10.1093.
- GEERTSEMA S, Fagundes RR, Otten AT, Dijkstra G, et al
Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance.
Inflamm Bowel Dis. 2024 Mar 5:izae042. doi: 10.1093.
- PILLAY L, Subramanian S
The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Mar 7:izae025. doi: 10.1093.
J Crohns Colitis
- ELLRICHMANN M, Schulte B, Conrad CC, Schoch S, et al
Contrast enhanced endoscopic ultrasound detects early therapy response following
anti-TNF-therapy in patients with ulcerative colitis.
J Crohns Colitis. 2024 Mar 8:jjae034. doi: 10.1093.
- TEUGELS A, van den Eijnden I, Keersmaekers B, Verstockt B, et al
Disease acceptance, but not perceived control, is uniquely associated with
inflammatory bowel disease-related disability.
J Crohns Colitis. 2024 Mar 6:jjae025. doi: 10.1093.
- BIEL C, Faber KN, Bank RA, Olinga P, et al
Matrix metalloproteinases in intestinal fibrosis.
J Crohns Colitis. 2024;18:462-478.
- WARSOP ZI, Manzo CA, Yu N, Yusuf B, et al
Patient-reported Outcome Measures in Ileoanal Pouch Surgery: a Systematic Review.
J Crohns Colitis. 2024;18:479-487.
- JOJART B, Resal T, Kata D, Molnar T, et al
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring
Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.
J Crohns Colitis. 2024;18:392-405.
- WEBER S, Sitte S, Voegele AL, Sologub L, et al
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with
Inflammatory Bowel Diseases.
J Crohns Colitis. 2024;18:446-461.
Lancet
- DOLINGER M, Torres J, Vermeire S
Crohn's disease.
Lancet. 2024 Mar 1:S0140-6736(23)02586-2. doi: 10.1016/S0140-6736(23)02586.
PLoS One
- FU C, Wang Q, Chen Y, Zhang Y, et al
Exploring the causal relationship between airborne particulate matter and
ulcerative colitis: A two-sample mendelian randomization study.
PLoS One. 2024;19:e0300066.
- RIDSDALE K, Khurana K, Taslim AT, Robinson JK, et al
Quality improvement exercises in Inflammatory Bowel Disease (IBD) services: A
scoping review.
PLoS One. 2024;19:e0298374.
- WANG Z, Nie J, Song X, Denson LA, et al
A comparison of Bayesian and frequentist approaches to incorporating clinical and
biological information for the prediction of response to standardized pediatric
colitis therapy.
PLoS One. 2024;19:e0295814.
Scand J Gastroenterol
- MERTZ NIELSEN A, Theede K, Gluud LL, Kiszka-Kanowitz M, et al
Efficacy of optimised thiopurine therapy in patients with moderate-to-severe
ulcerative colitis: retrospective long-term follow-up from two randomised trials.
Scand J Gastroenterol. 2024 Mar 5:1-5. doi: 10.1080/00365521.2024.2323502.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016